Article
MYC dosage compensation is mediated by miRNA-transcription factor interactions in…
bioRxiv · 2021 · ManSai Acón
Key facts
| Title | MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer |
|---|---|
| First author | ManSai Acón |
| Journal | bioRxiv |
| Published | Oct 7, 2021 |
| DOI | 10.1101/2021.04.20.440572 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIT, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1